EPISODE · Apr 7, 2025 · 35 MIN
Elias Zerhouni and Andy Plump discuss the future of multispecific biologics
from The Studio at Kendall Square · host BiotechTV
Interviewed by Andy Plump, President of R&D at Takeda, Dr. Zerhouni discusses the rationale for multispecifics and the science behind them. They also discuss the differences between pharma and biotech, keys to being an effective R&D leader, and advice for both young and experienced people in their careers.
Embed this episode
Ready to play
Elias Zerhouni and Andy Plump discuss the future of multispecific biologics
0:00
35:49
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Studio at Kendall Square?
This episode is 35 minutes long.
When was this The Studio at Kendall Square episode published?
This episode was published on April 7, 2025.
Can I download this The Studio at Kendall Square episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!